Publication | Closed Access

Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial

HypertensionPulmonary Arterial HypertensionCardiovascular DiseaseAntihypertensive TherapyLong-term OutcomesPharmacotherapyPublic HealthMedicineLong-term Extension TrialChest-2 Open-labelPulmonary Vascular DiseaseAnesthesiology